WASHINGTON, May 17 (Reuters) - Jazz Pharmaceuticals Inc. on Thursday set its planned initial public offering at 6 million shares for an estimated price of $24 to $26 each.
WASHINGTON, May 17 (Reuters) - Jazz Pharmaceuticals Inc. on Thursday set its planned initial public offering at 6 million shares for an estimated price of $24 to $26 each.